Applications and benefits in cell therapy workflows
In this webinar, we discuss how the closed, automated Gibco CTS Rotea Counterflow Centrifugation System offers user-programmable software to enable the creation and optimization of protocols for a broad range of applications, and allows the system to seamlessly scale from process development to commercial manufacturing. For isolation of white blood cells (WBCs), leukopaks as well as whole blood can be used as starting material. The system is capable of using red blood cell (RBC) lysis buffer or density gradient reagents, while recovering 90% of WBCs, maintaining viability, and retaining less than 10% RBCs.
The CTS Rotea Counterflow Centrifugation System can perform a wide range of cell processing applications for cell therapy workflows in an automated closed system.
- Gain a greater understanding of the scope of the Rotea system applications within WBC isolation and buffer exchange
- Learn about the comprehensive ability of the Rotea system to efficiently wash out many types of medium components
- Understand how the Rotea system can be adapted to new applications by utilizing its user-programmable software
